117 STAT. 744
PUBLIC LAW 108–25—MAY 27, 2003 (ii) has demonstrated support for the proposed program from relevant government entities; and (iii) is able to provide HIV care, including antiretroviral treatment when medically indicated, to HIV positive women, men, and children with the support of the project funding. (3) LOCAL HEALTH AND INTERNATIONAL ORGANIZATIONS.— For purposes of paragraph (2)(A)— (A) the term ‘‘local health organization’’ means a public sector health system, nongovernmental organization, institution of higher education, community-based organization, or nonprofit health system that provides directly, or has a clear link with a provider for the indirect provision of, primary health care services; and (B) the term ‘‘international organization’’ means— (i) a nonprofit international entity; (ii) an international charitable institution; (iii) a private voluntary international entity; or (iv) a multilateral institution. (4) PRIORITY REQUIREMENT.—In awarding subgrants under this subsection, the organization shall give priority to eligible applicants that are currently administering a program of proven intervention to HIV positive individuals to prevent motherto-child transmission in countries with or at risk for severe HIV epidemic with particular attention to resource constrained countries, and who are currently administering a program to HIV positive women, men, and children to provide life-long care in family-centered care programs using non-Federal funds. (5) SELECTION OF SUBGRANT RECIPIENTS.—In awarding subgrants under this subsection, the organization should— (A) consider applicants from a range of health care settings, program approaches, and geographic locations; and (B) if appropriate, award not less than 1 grant to an applicant to fund a national system of health care delivery to HIV positive families. (6) USE OF SUBGRANT FUNDS.—An eligible entity awarded a subgrant under this subsection shall use subgrant funds to expand activities to prevent mother-to-child transmission of HIV by providing medical treatment and care and support services to parents and their children, which may include— (A) providing treatment and therapy, when medically indicated, to HIV-infected women, their children, and families; (B) the hiring and training of local personnel, including physicians, nurses, other health care providers, counselors, social workers, outreach personnel, laboratory technicians, data managers, and administrative support personnel; (C) paying laboratory costs, including costs related to necessary equipment and diagnostic testing and monitoring (including rapid testing), complete blood counts, standard chemistries, and liver function testing for infants, children, and parents, and costs related to the purchase of necessary laboratory equipment; (D) purchasing pharmaceuticals for HIV-related conditions, including antiretroviral therapies;
VerDate 11-MAY-2000
13:45 Aug 26, 2004
Jkt 019194
PO 00000
Frm 00770
Fmt 6580
Sfmt 6581
D:\STATUTES\2003\19194PT1.001
APPS10
PsN: 19194PT1
�
